Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call reveals declining revenues and client challenges due to market consolidation and industry pressures. Despite some positive aspects like strong liquidity management, the overall sentiment is negative due to revenue declines, legal and financial liabilities, and the impact of industry dynamics. The Q&A section didn't provide additional positive insights to alter this sentiment. Without a market cap, the exact impact is unclear, but the negative factors outweigh the positives, leading to a likely stock price decline in the range of -2% to -8%.
Full Year Revenue $175 million, a decline of approximately 5% year-over-year from $185 million in 2024. The decline was due to persistent challenges in core markets, including pricing compression, competition from illicit markets, and elevated excise tax burdens.
Fourth Quarter Revenue $43 million, a decline of 10% year-over-year. This was attributed to lower client spending due to tighter marketing budgets and challenges in core markets like California and Michigan.
Adjusted EBITDA (Full Year) $40 million, down from $43 million in 2024. Despite the revenue decline, cost control efforts helped maintain profitability.
Cash Balance (End of 2025) $62 million, an almost 20% increase from the end of 2024. This increase reflects strong liquidity management.
Average Paying Clients (Full Year) 5,190, up 2% year-over-year. Growth in newer markets like New York offset declines in mature markets like California and Michigan.
Average Revenue Per Paying Client (Full Year) Approximately $2,800, a decline from prior year levels. This was due to lower spending by existing clients and the addition of new clients in emerging markets who started with lower spending levels.
Operating Expenses (Full Year) $174 million, a 2% increase from $170 million in 2024. The increase was driven by nonrecurring items such as a $2.3 million noncash loss contingency and a $2.8 million legal settlement.
Net Income (Full Year) $3 million. This reflects the impact of cost control measures and nonrecurring expenses.
Product-first discovery and shopping journeys: Several product updates are underway to enable product-first discovery and shopping journeys, aiming to provide an e-commerce experience similar to other industries.
New market growth: Encouraging growth in newer markets such as New York and Ohio, with client penetration prioritized as retailers come online. Client count in New York nearly doubled compared to the prior year.
Expansion into new states: Plans to leverage learnings from New York to grow presence in other new markets like Minnesota and Texas.
Revenue performance: Full year 2025 revenue was $175 million, a 5% decline from 2024. Fourth quarter revenue was $43 million, down 10% year-over-year.
Cost management: Disciplined cost control resulted in a non-GAAP adjusted EBITDA of $40 million for 2025, compared to $43 million in 2024. Operating expenses increased modestly by 2% due to nonrecurring items.
Focus on large clients and MSOs: Deepening relationships with large California-based clients and MSO partners to adapt to market consolidation and competitive pressures.
Regulatory challenges: Cautious approach to Schedule III rescheduling, as it does not immediately allow new revenue strategies or e-commerce capabilities. Focus remains on building a broad marketplace for cannabis discovery and transactions.
Consolidation in the cannabis industry: The consolidation of operators in the cannabis industry reduces the number of market participants, which negatively impacts Weedmaps' platform performance as it thrives in regions with a larger and more competitive operator base. Additionally, product choice and shelf space are becoming streamlined, limiting brand availability for users.
Regulatory and operational constraints: Weedmaps faces restrictions due to its listing on a major U.S. exchange, which limits its ability to monetize cannabis technology, handle transactions, and logistics. This prevents the company from offering a standard e-commerce experience and fully leveraging its dual-sided marketplace.
Impact of Schedule III rescheduling: The rescheduling of cannabis to Schedule III will not make cannabis federally legal or allow Weedmaps to enter new business lines. The tax benefits of rescheduling are expected to favor large operators and MSOs, potentially accelerating market consolidation, which could further impact Weedmaps' business model.
Client financial pressures: Clients in core markets face severe pricing compression, competition from illicit markets, and elevated excise tax burdens, which reduce their margins and marketing budgets. This limits their ability to spend on Weedmaps' platform, particularly on featured and deals listings.
Decline in mature markets: Key markets like California and Michigan experienced declines in total retail sales and average retail prices, leading to reduced client spending and operator exits. This has negatively impacted Weedmaps' revenue and client base.
Legal and financial liabilities: Weedmaps incurred a $2.3 million noncash loss contingency related to a server provider contract and a $2.8 million legal settlement, as well as a $7.8 million noncash asset impairment charge, which affected its financial performance.
Revenue and client challenges: Revenue declined by 10% year-over-year in Q4 2025, and average paying clients decreased by 2% due to market consolidation and operator exits. Average revenue per paying client also dropped due to tighter marketing budgets and lower initial spend levels in newer markets.
Revenue Projections: First quarter revenue is expected to decline sequentially by mid- to high single digits from the fourth quarter of 2025.
Investment Plans: The company plans to continue investing opportunistically across the business in 2026, focusing on enhancing product offerings, deepening relationships with key clients, and improving marketplace experience.
Market Expansion: Weedmaps aims to leverage early momentum in New York and expand its presence in new markets like Minnesota and Texas, as well as regulatory capture markets where it has historically had less presence.
Industry Dynamics: The cannabis industry is expected to face continued consolidation and structural challenges, impacting Weedmaps' business model due to reduced operator numbers and streamlined product choices.
Schedule III Rescheduling Impact: The rescheduling of cannabis to Schedule III is not expected to significantly impact Weedmaps' business in the near term, as it will not make cannabis federally legal or allow new revenue strategies. The tax benefits of rescheduling are likely to favor large operators and MSOs, potentially affecting Weedmaps' business model.
The selected topic was not discussed during the call.
The earnings call reveals declining revenues and client challenges due to market consolidation and industry pressures. Despite some positive aspects like strong liquidity management, the overall sentiment is negative due to revenue declines, legal and financial liabilities, and the impact of industry dynamics. The Q&A section didn't provide additional positive insights to alter this sentiment. Without a market cap, the exact impact is unclear, but the negative factors outweigh the positives, leading to a likely stock price decline in the range of -2% to -8%.
The earnings call highlights revenue decline, price compression, and regulatory challenges, which are significant concerns. While the company maintains profitability and cash reserves, the negative trends in core markets and client churn overshadow the positives. The lack of clear guidance and the focus on long-term prospects at the expense of near-term revenue add to the uncertainty, suggesting a negative market reaction.
The earnings call summary presents mixed signals. While there is modest revenue growth and positive cash generation, regulatory challenges and declining client spending pose risks. The Q2 guidance shows stability but lacks significant upside. Product development and client base growth are positive, but operational challenges and market pressures could offset gains. Without a strong catalyst or significant market cap details, the stock price is likely to remain stable in the near term.
The earnings call presented mixed signals. Positive aspects include revenue and EBITDA exceeding guidance, sequential growth, and a share buyback program. However, the EPS miss, regulatory risks, and competitive pressures introduce uncertainties. The Q&A highlighted ongoing challenges in the cannabis industry and lack of clarity on regulatory strategies. These factors balance out, leading to a neutral sentiment.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.